Remote patient monitoring is steadily reshaping chronic disease care, but its role in inflammatory bowel disease is only now coming into focus. This comprehensive review traces how connected technologies—ranging from home biomarker testing and wearable sensors to passive physiologic monitoring—are being adapted for IBD, drawing lessons from cardiology, endocrinology, and psychiatry. It highlights promising signals around earlier flare detection, patient engagement, and proactive care, while also confronting the unresolved challenges of adherence, regulation, reimbursement, and workflow integration. What emerges is not a finished solution, but a rapidly evolving model of care whose real impact on IBD management is still being defined.
Previous ArticleHow physicians can negotiate work relative value unit contracts with large health systems (Healio)
Next Article Top 10 ASC News Stories of 2025 (ASC News)
Keep Reading
Add A Comment
